PANews reported on July 19th that, according to Cryptoslate, Injective Labs has partnered with 21Shares to announce the launch of AINJ - an Injective Exchange Traded Product (ETP) pegged to INJ, which will include staking features. This fund will allow users to access INJ tokens through major traditional financial exchanges and brokerage firms while receiving staking rewards. The ETP will be traded at the Amsterdam division (AINJ NA) and Paris division (AINJ FP) of the Pan-European Exchange. It will be supported by 25 different banks and brokers, including Interactive Brokers, Saxo Bank, Swissquote and eToro.